| Financial Year |
March 31 2023 |
| Monetary Funds |
1,542,345,031.58 |
| Held-for-trading Financial Assets |
496,202.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
321,043,338.42 |
| Advances to Suppliers |
124,150,801.68 |
| Other Receivables |
11,203,743.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,044,691,680.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,227,421.60 |
| Total Current Assets |
3,094,158,219.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
600,669,322.22 |
| Under-construction Projects |
159,944,903.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,684,740,088.55 |
| R&D expenses |
-- |
| Goodwill |
143,077,713.05 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
166,781,040.32 |
| Other Non-Current Assets |
38,097,583.17 |
| Sub-Total of Non-Current Assets |
3,933,304,101.72 |
| Total Assets |
7,027,462,320.73 |
| Short-Term Loans |
1,162,046,837.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,000,000.00 |
| Accounts Payable |
432,125,863.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,169,553.55 |
| Taxes Payable |
11,778,367.23 |
| Interest Payable |
-- |
| Dividend Payable |
2,378,203.02 |
| Other payables |
140,412,771.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
103,290,280.08 |
| Other Current Liabilities |
14,024,027.30 |
| Sub-Total of Current Liabilities |
2,055,599,996.53 |
| Long-term Loans |
720,482,715.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
171,792.50 |
| Deferred Income Tax Liabilities |
387,575,829.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,131,114,879.34 |
| Total Liabilities |
3,186,714,875.87 |
| Paid-In Capital(Or Share Stock) |
1,079,428,095.00 |
| Capital Surplus |
1,602,287,899.27 |
| Surplus Reserve |
163,369,948.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
384,109,750.43 |
| Minority Stockholder's Interest |
581,579,363.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,259,168,081.69 |
| Owner's Equity（Stockholder's Equity） |
3,840,747,444.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,027,462,320.73 |
